Discounted Ustekinumab Biosimilars Further Dent J&J’s Q1 Stelara Sales

As Biosimilars Push Competition And Dynamic Pricing Strategies

 
• By Urtė Fultinavičiūtė
  
Hand putting wood cubes with percentage icon
(Shutterstock)

More from Biosimilars

More from Generics Bulletin